Wai Yuen Tong Medicine Holdings

Name

Wai Yuen Tong Medicine Holdings

Legal name

Wai Yuen Tong Medicine Holdings Limited

Website

https://wyth.net

Company type

Public

Founded year

2002

Operating status

Operating

Headcount range

501–1,000 employees

Ownership category

akta.pro rank

Product category

Traditional Chinese & Western Pharmaceuticals

NAICS

Pharmaceutical and Medicine Manufacturing (32541), Medicinal and Botanical Manufacturing (325411)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro industry

PRIMARYCRADAMAD

Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges)

Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)

SECONDARYHLAIACAF

Pulmonology & Allergy Specialty Pharmaceuticals

Healthcare & Life Sciences/Pharmaceuticals/Specialty Pharmaceuticals

Keywords

• Traditional Chinese medicine
• Western pharmaceutical products
• Pharmaceutical manufacturing
• Cough syrup remedies
• Chinese herbal medicines

Headquarters

HQ city

Central

HQ country

Hong Kong SAR China

HQ region

Asia

Offices2 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Infrastructure, Marketing or Sales

Revenue model

1. Pharmaceutical Products Sales: Manufacturing and distribution of Chinese and Western pharmaceutical products under household brands Wai Yuen Tong, Madame Pearl's, and Pearl's. Revenue generated through retail pharmacy channels and brand outlets.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Wai Yuen Tong Medicine Holdings manufactures and sells Chinese and Western pharmaceutical and healthcare products through two household brands — "Wai Yuen Tong" for traditional Chinese medicine remedies (including Hou Tsao Powder) and "Madame Pearl's"/"Pearl's" for Western medicines such as cough syrups. Products are produced in a PIC/S-compliant GMP factory at Yuen Long Industrial Estate and distributed through retail pharmacy networks in Hong Kong and the Greater Bay Area.

Product overview

Wai Yuen Tong Medicine Holdings operates a dual-brand pharmaceutical portfolio strategy through two core brands. The company manufactures and distributes traditional Chinese medicine products under the 'Wai Yuen Tong' brand, while simultaneously operating Western medicine products under the 'Madame Pearl's' and 'Pearl's' brands through Luxembourg Medicine Company Limited. In 2025, the company launched an innovative AI TCM Constitution Identification Device, marking its entry into digital health technology. Additionally, its Wai Yuen Tong Hou Tsao Powder became the first Hong Kong traditional oral Chinese medicine approved for mainland China market access. All products are manufactured in GMP-certified facilities compliant with PIC/S international pharmaceutical standards.

Differentiator

Problem solved

Functional benefit

Products and services

• Wai Yuen Tong (Traditional Chinese Medicine brand) Traditional Chinese medicine product line offering a range of Chinese pharmaceutical and healthcare products, including herbal remedies and medicinal preparations for various health conditions, sold to general consumers in Hong Kong and the Greater Bay Area.
• Madame Pearl's (Western medicine brand) Western medicine brand specializing in cough syrups and respiratory medications, manufactured by Luxembourg Medicine Company Limited and sold to general consumers.
• Pearl's (Western medicine brand) Western medicine brand offering pharmaceutical products that complement the Madame Pearl's product line under the Luxembourg Medicine Company Limited portfolio.
• Wai Yuen Tong Hou Tsao Powder Traditional oral Chinese medicine powder for treating phlegm and respiratory conditions. Became the first Hong Kong traditional oral Chinese medicine approved for sale in mainland China in October 2025.
• AI TCM Constitution Identification Device Hong Kong's first smart AI constitution analysis device for traditional Chinese medicine, providing personalized health recommendations based on TCM diagnostic principles.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature1 record

Scale indicators3 records

Recent moves7 records

Expansion highlights4 records

Regional players

• L'Occitane International: Hong Kong-listed consumer health/wellness brand with regional retail presence and TCM-inspired botanical product lines, comparable as a HK-listed heritage health brand.

Broad incumbents

• China Resources Pharmaceutical Group: Large state-affiliated pharmaceutical conglomerate with significant TCM and OTC pharmaceutical operations across mainland China and Hong Kong.
• Hutchison China MediTech (Chi-Med): Hong Kong-listed pharma group with both TCM consumer health and innovative drug operations; comparable as a HK-listed Chinese pharma peer with diversified healthcare exposure.
• China Traditional Chinese Medicine Holdings: Large-scale Hong Kong-listed TCM manufacturer under Sinopharm group with significantly broader product portfolio and mainland China distribution scale.
• Bayer Consumer Health: Major multinational OTC and consumer health company with extensive cough/cold and TCM-adjacent product lines, competing in similar respiratory and wellness categories globally.
• Reckitt Benckiser (Mucinex/Nurofen): Global OTC leader in cough/cold/respiratory categories including brands like Mucinex and Nurofen, comparable product category to Madame Pearl's Cough Syrup and other OTC offerings.
• Guangzhou Baiyunshan Pharmaceutical Holdings: Major Chinese pharmaceutical conglomerate with strong TCM portfolio and extensive Greater Bay Area manufacturing and retail presence, comparable in category but far larger in scale.

Emerging players

• Yiling Pharmaceutical: Chinese TCM-focused pharmaceutical company with branded TCM products for respiratory and chronic conditions, overlapping with Wai Yuen Tong's Madame Pearl's cough/respiratory category.

Direct peers

• PuraPharm International Group: Hong Kong-listed Chinese medicine manufacturer with similar focus on TCM products, GMP-certified manufacturing, and Hong Kong distribution. Closest direct competitor in the HK TCM OTC segment.
• Beijing Tong Ren Tang Chinese Medicine: Iconic TCM brand with Hong Kong retail presence and mainland China cross-border operations. Comparable heritage brand positioning and dual Chinese/Western product strategy.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/wai-yuen-tong-medicine-holdings-ltd.

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Wai Yuen Tong Medicine Holdings